Home >  News >  Industry >  Pharma News >  Roche, Rotary India...

Roche, Rotary India Literacy Mission collaborate for diabetes management

By - Ruchika Sharma
Published On 2021-06-16 06:30 GMT   |   Update On 2021-06-16 12:16 GMT
Advertisement

New Delhi: Roche Diabetes Care (RDC) India has announced that the company has signed a Memorandum of Understanding (MoU) with Rotary India Literacy Mission (RILM) to conduct diabetes screening camps for the underprivileged across India, to drive early detection of diabetes and to increase awareness about its management.

Recent reports have flagged the potential 'diabetogenic' effect of Covid-19 on people who did not have diabetes before their exposure to this virus.

Omar Sherief Mohammad, Managing Director, Roche Diabetes Care India, said, "India already has a huge burden of diabetes and we would like to address the new risk that Covid-19 now poses. At Roche Diabetes Care, our aim is to provide true relief to people with diabetes everywhere so that they can keep their sugar levels under control. This is particularly important once the Covid-19 pandemic waves subsides, and we have to contend with possible long-term health impacts of the disease. We believe that joining hands with like-minded partners such as RILM can help us create a nationwide network to provide early diagnosis of diabetes and create awareness among the underprivileged."
Advertisement
During the pilot phase of the project, a total of 300 screening camps will be organised in six states- Maharashtra, UP, Sikkim, WB, Telengana, Karnataka - over six months. This will later be scaled-up to include the rest of the country in a phased approach. A soon as the situation permits, RILM will organize diabetes detection screening camps for the underprivileged, with a focus on schoolchildren and their parents at government aided schools. RDC will support RILM by providing glucometer kits, test strips and lancets for early detection and diagnosis of diabetes.
Kamal Sanghvi, Rotary International Director and RILM Chairman, said, "We are proud and privileged to join hands with Roche Diabetes Care to screen for and create awareness about diabetes. Early detection is absolutely critical if we are to reduce the high burden of diabetes in India. Rotary has a legacy of helping to eradicate diseases that become a huge public health challenge, as we did for polio, and now we would like to provide support for diabetes control. We remain committed to ensuring that the underprivileged are not left behind as we move forward into a post-pandemic era."
According to the International Diabetes Federation (IDF), about 463 million people are affected with diabetes mellitus worldwide, and this number is estimated to reach 700 million by 2045. India ranks second in the world, as almost 77 million Indians have diabetes
Dr. Bal Inamdar, Chair, Curative Health, Rotary India said "Rotary is known around the world for its larger-than-life vision and action. Now, we are pleased to partner with one of the world's most respected pharmaceutical companies, Roche Diabetes Care, to tackle one of the world's biggest healthcare challenges: diabetes, in India. This can only lead to great action and great results! I wish this collaboration all the success that it so richly deserves!"



Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News

Roche gets negative EMA Committee opinion on Elevidys CMA for 3-7 year olds with Duchenne muscular dystrophy

Expert Committee Clears Ravenbhel to Begin Resmetirom Phase 3 Trial, Asks for BE Data First

Menopause relief drug: USFDA extends review period for Bayer Elinzanetant

Roche receives CE Mark for minimally invasive blood test to help rule out Alzheimer's disease

Troikaa's Fast-Acting Paracetamol Shot Hits Regulatory Hurdle, CDSCO Panel Seeks More Data

Sanofi Sarclisa approved in EU for transplant-eligible newly diagnosed multiple myeloma

Pharma Firm Ignored Safety Gaps Before Deadly Blast, Paid Rs 32 Cr To Victims, Parliament Informed

GSK Blenrep combos approved in EU for treatment of relapsed/refractory multiple myeloma